Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition

Neurobiology of Disease

Volumn 15, Issue 3, 2004, Pages 640-647

  Song, Sheng Kwei ^a,b,c   Kim, Joong Hee ^a   Lin, Shiow Jiuan ^c   Brendza, Robert P ^c   Holtzman, David M ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Axon; Diffusion tensor; Mice; MRI; Myelin; PDAPP; White matter

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PROTEIN; PLATELET DERIVED GROWTH FACTOR;

AMYLOID NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; EVALUATION; GENE OVEREXPRESSION; MOUSE; MYELINATED NERVE; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPECIES COMPARISON; TRANSGENIC MOUSE; WHITE MATTER;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); SENILE PLAQUES;

EID: 1842588702     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.12.003     Document Type: Article

References (50)

1. Barber R., Scheltens P., Gholkar A., Ballard C., McKeith I., Ince P., Perry R., O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J. Neurol. Neurosurg. Psychiatry. 67:1999;66-72.
2. Basser P.J., Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J. Magn. Reson., Ser. B. 111:1996;209-219.
3. Basser P.J., Pierpaoli C. A simplified method to measure the diffusion tensor from seven MR images. Magn. Reson. Med. 39:1998;928-934.
4. Bozzali M., Falini A., Franceschi M., Cercignani M., Zuffi M., Scotti G., Comi G., Filippi M. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry. 72:2002;742-746.
5. Bozzao A., Floris R., Baviera M.E., Apruzzese A., Simonetti G. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am. J. Neuroradiol. 22:2001;1030-1036.
6. Bronge L., Bogdanovic N., Wahlund L.O. Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement. Geriatr. Cogn. Disord. 13:2002;205-212.
7. Brun A., Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 19:1986;253-262.
8. Chun T., Filippi C.G., Zimmerman R.D., Ulug A.M. Diffusion changes in the aging human brain. AJNR Am. J. Neuroradiol. 21:2000;1078-1083.
9. de Groot J.C., de Leeuw F.E., Oudkerk M., van Gijn J., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and cognitive function: the Rotterdam scan study. Ann. Neurol. 47:2000;145-151.
10. de Groot J.C., de Leeuw F.E., Oudkerk M., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam scan study. Neurology. 56:2001;1539-1545.
11. de Leeuw F.E., de Groot J.C., Achten E., Oudkerk M., Ramos L.M., Heijboer R., Hofman A., Jolles J., van Gijn J., Breteler M.M. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam scan study. J. Neurol. Neurosurg. Psychiatry. 70:2001;9-14.
12. DeMattos R.B., O'Dell M.A., Parsadanian M., Taylor J.W., Harmony J.A., Bales K.R., Paul S.M., Aronow B.J., Holtzman D.M. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10843-10848.
13. Desmond D.W. Cognition and white matter lesions. Cerebrovasc. Dis. 13(Suppl. 2):2002;53-57.
14. Engelter S.T., Provenzale J.M., Petrella J.R., DeLong D.M., MacFall J.R. The effect of aging on the apparent diffusion coefficient of normal-appearing white matter. AJR Am. J. Roentgenol. 175:2000;425-430.
15. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. NeuroReport. 4:1993;523-526.
16. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F.et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
17. Giannakopoulos P., Hof P.R., Bouras C. Selective vulnerability of neocortical association areas in Alzheimer's disease. Microsc. Res. Tech. 43:1998;16-23.
18. Hampel H., Teipel S.J., Alexander G.E., Pogarell O., Rapoport S.I., Moller H.J. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J. Neural Transm. 109:2002;837-855.
19. Han X., Holtzman D.M., McKeel D.W. Jr. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77:2001;1168-1180.
20. Han X., Holtzman D.M., McKeel D.W. Jr., Kelley J., Morris J.C. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J. Neurochem. 82:2002;809-818.
21. Hanyu H., Asano T., Sakurai H., Imon Y., Iwamoto T., Takasaki M., Shindo H., Abe K. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease. J. Neurol. Sci. 167:1999;37-44.
22. Hirono N., Kitagaki H., Kazui H., Hashimoto M., Mori E. Impact of white matter changes on clinical manifestation of Alzheimer's disease: a quantitative study. Stroke. 31:2000;2182-2188.
23. Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J., Mackey B., Olney J., McKeel D., Wozniak D., Paul S.M. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2892-2897.
24. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
25. Ishimaru M.J., Ikonomidou C., Tenkova T.I., Der T.C., Dikranian K., Sesma M.A., Olney J.W. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J. Comp. Neurol. 408:1999;461-476.
26. Ivins K.J., Thornton P.L., Rohn T.T., Cotman C.W. Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol. Dis. 6:1999;440-449.
27. Jen L.S., Hart A.J., Jen A., Relvas J.B., Gentleman S.M., Garey L.J., Patel A.J. Alzheimer's peptide kills cells of retina in vivo. Nature. 392:1998;140-141.
28. Kantarci K., Jack C.R. Jr., Xu Y.C., Campeau N.G., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Kokmen E., Tangalos E.G., Petersen R.C. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology. 219:2001;101-107.
29. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;5795-5811.
30. Meyer J.S., Kawamura J., Terayama Y. White matter lesions in the elderly. J. Neurol. Sci. 110:1992;1-7.
31. Morrison P.R.H.a.J.H. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. Terry R.K.R.D., Bick K.L., Sisodia S.S. Alzheimer Disease. 1999;207-232 Lippincott Williams & Wilkins, Philadelphia.
32. Mudher A., Lovestone S. Alzheimer's disease - do tauists and baptists finally shake hands? Trends Neurosci. 25:2002;22-26.
33. Nusbaum A.O., Tang C.Y., Buchsbaum M.S., Wei T.C., Atlas S.W. Regional and global changes in cerebral diffusion with normal aging. AJNR Am. J. Neuroradiol. 22:2001;136-142.
34. O'Brien J.T., Ames D. White matter lesions in depression and Alzheimer's disease. Br. J. Psychiatry. 169:1996;671.
35. O'Brien J., Perry R., Barber R., Gholkar A., Thomas A. The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Ann. N. Y. Acad. Sci. 903:2000;482-489.
36. Olichney J.M., Hansen L.A., Lee J.H., Hofstetter C.R., Katzman R., Thal L.J. Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease. Ann. N. Y. Acad. Sci. 903:2000;138-143.
37. O'Sullivan M., Jones D.K., Summers P.E., Morris R.G., Williams S.C., Markus H.S. Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology. 57:2001;632-638.
38. Pfefferbaum A., Sullivan E.V., Hedehus M., Lim K.O., Adalsteinsson E., Moseley M. Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn. Reson. Med. 44:2000;259-268.
39. Pierpaoli C., Jezzard P., Basser P.J., Barnett A., Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology. 201:1996;637-648.
40. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 45:1999;358-368.
41. Price J.L., Ko A.I., Wade M.J., Tsou S.K., McKeel D.W., Morris J.C. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch. Neurol. 58:2001;1395-1402.
42. Redwine J.M., Kosofsky B., Jacobs R.E., Games D., Reilly J.F., Morrison J.H., Young W.G., Bloom F.E. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis. Proc. Natl. Acad. Sci. USA. 100:2003;1381-1386.
43. Rose S.E., Chen F., Chalk J.B., Zelaya F.O., Strugnell W.E., Benson M., Semple J., Doddrell D.M. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J. Neurol. Neurosurg. Psychiatry. 69:2000;528-530.
44. Scheltens P., Barkhof F., Leys D., Wolters E.C., Ravid R., Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology. 45:1995;883-888.
45. Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage. 17:2002;1429-1436.
46. Stewart R. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam scan study. Neurology. 57:2001;2149.
47. Takahashi S., Yonezawa H., Takahashi J., Kudo M., Inoue T., Tohgi H. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci. Lett. 332:2002;45-48.
48. Teipel S.J., Bayer W., Alexander G.E., Zebuhr Y., Teichberg D., Kulic L., Schapiro M.B., Moller H.J., Rapoport S.I., Hampel H. Progression of corpus callosum atrophy in Alzheimer disease. Arch. Neurol. 59:2002;243-248.
49. Xu J., Chen S., Ahmed S.H., Chen H., Ku G., Goldberg M.P., Hsu C.Y. Amyloid-beta peptides are cytotoxic to oligodendrocytes. J. Neurosci. 21:2001;RC118.
50. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature. 407:2000;802-809.